The clinical significance of PD-1 expression in patients with bladder cancer without lymph node metastasis: a comparative study with drained lymph nodes and tumor tissues-Reference-Cited by-同舟云学术

The clinical significance of PD-1 expression in patients with bladder cancer without lymph node metastasis: a comparative study with drained lymph nodes and tumor tissues

Published:2024-05-14 Issue: Volume: Page:1-17
ISSN:0020-7454
Container-title:International Journal of Neuroscience
language:en
Short-container-title:International Journal of Neuroscience

Author:

Zheng Wei¹,Zhang Pu¹,Yao Cenchao²,Tao Yutao²,Wang Zhida³,Meng Shuai⁴

Affiliation:

1. Urology & Nephrology Center, Department of Urology, Zhejiang Provincial People's Hospital(Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China

2. The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou 310053, China

3. Postgraduate Training Base Alliance of Zhejiang Provincial People's Hospital, Wenzhou Medical University, Hangzhou, Zhejiang, China

4. Department of Urology, First Affiliated Hospital, School of Medicine, Zhejiang University

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/00207454.2024.2356152

Reference25 articles.

1. Bardoli A. D. Afshar M. Viney R. Foster M. Porfiri E. Zarkar A. Stevenson R. James N. D. Bryan R. T. & Patel P. (2016). The PD-1/PD-L1 axis in the pathogenesis of urothelial bladder cancer and evaluating its potential as a therapeutic target. Future Oncology 12(5) 595-600.

2. Bellmunt J. Powles T. & Vogelzang N. J. (2017). A review on the evolution of PD-1/PD-L1 immunotherapy for bladder cancer: the future is now. Cancer treatment reviews 54 58-67.

3. Chen R. Zhou X. Liu J. & Huang G. (2019). Relationship between the expression of PD-1/PD-L1 and 18 F-FDG uptake in bladder cancer. European journal of nuclear medicine and molecular imaging 46 848-854.

4. de Jong F. C. Rutten V. C. Zuiverloon T. C. & Theodorescu D. (2021). Improving anti-PD-1/PD-L1 therapy for localized bladder cancer. International journal of molecular sciences 22(6) 2800.

5. Fan Z. Liang Y. Yang X. Li B. Cui L. Luo L. Jia Y. Wang Y. & Niu H. (2019). A meta-analysis of the efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors as treatments for metastatic bladder cancer. OncoTargets and therapy 12 1791.